Elanco Animal Health Incorporated (ELAN) vs Takeda Pharmaceutical Co. (TAK)

Elanco Animal Health Incorporated and Takeda Pharmaceutical Co. are both Drug Manufacturers Specialty & Generic companies. Takeda Pharmaceutical Co. is the larger, with a market value of $59.2B against $11.2B — 5.3× the size. Elanco Animal Health Incorporated has negative trailing earnings, so its P/E is not meaningful; Takeda Pharmaceutical Co. trades at 28.4×. Elanco Animal Health Incorporated grew revenue faster over the last twelve months: 12.0% against 0.66%. Takeda Pharmaceutical Co. has the higher net margin (7.12% vs −3.96%) and the higher return on invested capital (2.88% vs 0.51%). Across the 20 metrics below, Takeda Pharmaceutical Co. leads on 13 and Elanco Animal Health Incorporated on 7.

Valuation

Metric ELAN TAK Drug Manufacturers Specialty & Generic median
P/E n/m 28.36 20.14
P/S 2.22 1.99 2.25
P/B 1.69 1.25 1.90
Price to free cash flow 31.22 8.03 16.54
EV/EBITDA 18.78 10.48 12.29
EV/Sales 2.89 2.91 2.56
Earnings yield (1.84%) 3.53% (2.99%)
Free cash flow yield 3.20% 12.46% 0.00%

Profitability

Metric ELAN TAK Drug Manufacturers Specialty & Generic median
Gross margin 55.36% 65.85% 53.94%
Operating margin 1.61% 11.61% 0.00%
Net margin (3.96%) 7.12% 0.00%
Free cash flow margin 7.55% 24.74% 0.00%
Return on equity (2.98%) 4.42% (0.40%)
Return on assets (1.46%) 2.15% (3.32%)
Return on invested capital 0.51% 2.88% 0.00%

Growth

Metric ELAN TAK Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 11.95% 0.66% 10.01%
EPS growth (last fiscal year) (169.12%) (244.86%) —
Revenue growth, 5-year CAGR 7.59% (0.21%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ELAN TAK Drug Manufacturers Specialty & Generic median
Debt to equity 0.59 0.65 0.05
Current ratio 2.05 1.14 2.31
Net debt to EBITDA 5.00 5.84 0.85

Dividend

Metric ELAN TAK Drug Manufacturers Specialty & Generic median
Dividend yield — 4.52% 1.70%
Payout ratio 0.00 0.50 0.00

Size

Metric ELAN TAK Drug Manufacturers Specialty & Generic median
Market cap 11.21b 59.16b 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack